HIGHLIGHTS
- who: Yang Yang from the AstraZeneca, United States University, China have published the research work: The role of obesity, type 2 diabetes, and metabolic factors in gout: A Mendelian randomization study, in the Journal: (JOURNAL)
- what: To control for false positive findings due to multiple testing, a conservative Bonferroni correction adjusted for the number of primary exposures analyzed in the study was applied, and P-values less than 0.003 were considered statistically significant. The analysis showed that genetically predicted fasting insulin, BMI, TG, blood pressure, and ALT were robust associated with gout or serum . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.